Industry
Biotechnology
Clearmind Medicine Inc., a pre-clinical pharmaceutical company, develops novel psychedelic medicines to treat under-served health problems. It develops treatments for alcohol use disorders, including binge drinking and eating disorders, as well as depression, binge eating, psychotherapy, mental health issues, and other binge behaviors. The company was formerly known as Cyntar Ventures Inc. and changed its name to Clearmind Medicine Inc. in March 2021. Clearmind Medicine Inc. was incorporated in 2017 and is based in Vancouver, Canada.
Loading...
Open
1.40
Mkt cap
5.7M
Volume
41K
High
1.40
P/E Ratio
-1.14
52-wk high
6.80
Low
1.36
Div yield
N/A
52-wk low
0.92
Portfolio Pulse from Benzinga Newsdesk
March 13, 2024 | 12:15 pm
Portfolio Pulse from Vandana Singh
February 27, 2024 | 12:30 pm
Portfolio Pulse from Benzinga Newsdesk
February 27, 2024 | 12:30 pm
Portfolio Pulse from Benzinga Newsdesk
February 23, 2024 | 12:08 pm
Portfolio Pulse from Patricio Liddle
February 21, 2024 | 4:12 pm
Portfolio Pulse from Erica Kollmann
February 20, 2024 | 6:29 pm
Portfolio Pulse from Benzinga Newsdesk
February 20, 2024 | 12:17 pm
Portfolio Pulse from Benzinga Newsdesk
February 05, 2024 | 12:52 pm
All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.